Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
OPRX
#3141
OptimizeRx Corporation Common Stock
7.5
8
-2.82%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-2.82%
Monatliche Änderung
-35.82%
6 month change
-56.78%
Jahresänderung
+46.05%
Vorheriger Schlusskurs
7.8
0
Open
7.5
8
Bid
Ask
Low
7.5
8
High
7.5
8
Volumen
33
Märkte
Aktien
Gesundheitswesen
OPRX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
16.81 M
17.88 M
17.1 M
18.18 M
18.49 M
—
Valuation ratios
Enterprise value
513.18 M
1.03 B
274.54 M
241.45 M
76.48 M
816.74 M
Price to earnings ratio
207.73
3 105.5
-26.75
-13.63
-4.42
-184.65 P
Price to sales ratio
10.67
17.93
4.88
3.36
0.97
8.55
Price to cash flow ratio
73.22
1 513.36
28.58
-33.21
18.18
99.24
Price to book ratio
9.25
8.36
2.41
1.9
0.76
2.45
Enterprise value to EBITDA ratio
-3 124.66
440.83
-26.74
-10.06
-8.95
153.31
Profitability ratios
Return on assets %
0.04
0
-0.08
-0.1
0.12
0.03
Return on equity %
0.04
0
-0.09
-0.14
0.17
0.04
Return on invested capital %
20.77
2.9
-90.08
-68.54
34.42
14.43
Gross margin %
55.65
58.14
62.4
59.98
64.45
260.03
Operating margin %
4.93
0.59
-19.68
-36.91
14.88
17.18
EBITDA margin %
-0.38
3.8
-16.44
-33.56
-9.27
37.29
Net margin %
5.1
0.62
-18.32
-24.56
21.83
18.51
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.28
12.29
11.74
3.04
2.89
11.33
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.74
0.61
0.45
0.45
0.52
0.65
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.19
0.18
0.65
Long term debt to total equity ratio
—
—
—
0.27
0.26
0.93
Per share metrics
Operating cash flow per share
0.43
0.04
0.6
-0.42
0.27
0.62
EBIT per share
-0.14
0.02
-0.69
-1.54
-0.75
0.36
EBITDA per share
-0.01
0.13
-0.58
-1.4
-0.47
0.64
Total debt per share
—
—
—
—
—
—
Cash per share
0.71
4.79
4.17
0.81
0.73
4.84
Net current asset value per share
2.22
6.51
5.54
3.17
2.95
11.49
Tangible book value per share
1.56
5.99
5.39
-1.7
0.03
9.35
Working capital per share
1.54
5.98
5.07
2.13
1.93
7.42
Book value per share
3.37
7.43
7.09
7.39
6.4
25.25
Nachrichten
Intuit (INTU) Q2 Earnings and Revenues Top Estimates
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength?
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
OptimizeRx: Finanzvorstand veräußert Aktien im Wert von 18.751 $
Halozyme beruft Branchenveteran Jim Lang in den Verwaltungsrat
New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript
Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates
OPTIMIZERx earnings beat by $0.16, revenue topped estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Citizens hebt Kursziel für OptimizeRX auf 23 US-Dollar an/n